306
Participants
Start Date
May 31, 2000
Primary Completion Date
October 31, 2000
Study Completion Date
March 31, 2003
Tafenoquine
Tafenoquine 200 mg for three days followed by Tafenoquine 200 mg once a week for 24 weeks.
Mefloquine
Mefloquine 250 mg for three days followed by Mefloquine 250 mg once a week for 24 weeks.
Placebo
Placebo for three days followed by placebo once a week for 24 weeks
Collaborators (1)
SmithKline Beecham
INDUSTRY
U.S. Army Medical Research and Development Command
FED